Grifols' decision to take legal action is a strong response to the allegations made by Gotham City Research. This move could be viewed positively by investors as it shows the company's commitment to defending its reputation and addressing concerns that may have affected its stock price. The legal process may take time, but the announcement itself could lead to a short-term positive impact on the stock as it may alleviate some of the concerns of stakeholders, patients, and donors.